MARKET

MYOS

MYOS

MYOS RENS
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.375
-0.325
-19.12%
Pre Market: 1.380 +0.005 +0.36% 05:47 07/07 EDT
OPEN
1.550
PREV CLOSE
1.700
HIGH
1.650
LOW
1.360
VOLUME
1.92M
TURNOVER
--
52 WEEK HIGH
3.850
52 WEEK LOW
0.7412
MARKET CAP
15.17M
P/E (TTM)
-3.0774
1D
5D
1M
3M
1Y
5Y

Analyst Price Target

The average MYOS stock price target is 3.750 with a high estimate of 3.750 and a low estimate of 3.750.

EPS

MYOS News

More
Myos Rens Technology shares are trading lower. Not seeing any company-specific news to justify the price action.
Benzinga · 16h ago
PSXP, KNDI, GNUS and SOLO among midday movers
Seeking Alpha - Article · 17h ago
66 Biggest Movers From Thursday
Gainers GEE Group, Inc. (NYSE: JOB) shares climbed 199.9% to close at $1.54 on Thursday after the company eliminated over $47 million in debt and mezzanine financing.
Benzinga · 1d ago
NUS, CPST, SOLO and MEIP among midday movers
Seeking Alpha - Article · 4d ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of MYOS RENS Technology Inc. with MedAvail, Inc. is Fair to MYOS Shareholders
Newsfile · 4d ago
Why Shares of Myos Rens Are Spiking Higher
Shares of nutrition company MYOS Corporation (NASDAQ: MYOS) were more than doubling Wednesday.
Benzinga · 5d ago
TTOO, MMLP, INO and BLNK among midday movers
Seeking Alpha - Article · 5d ago
MYOS RENS and MedAvail to merge, spin-out the muscle health business
Seeking Alpha - Article · 6d ago

Industry

Food Processing
+0.52%
Food & Tobacco
+0.43%

Hot Stocks

Symbol
Price
%Change

About MYOS

MYOS RENS Technology Inc. is focused on the discovery, development and commercialization of nutritional ingredients, functional foods, and other technologies for maintaining or improving the health and performance of muscle tissue. Its research is focused on developing strategies and therapeutic interventions to address muscle-related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases. The Company, through its subsidiary, holds the intellectual property pertaining to Fortetropin, which is a dietary supplement that has been shown in clinical studies to temporarily decrease the levels of serum myostatin, MYO-T12, a formulation containing Fortetropin. Fortetropin is the Company’s all-natural food ingredient clinically shown to enhance muscle size, lean body mass and strength as part of resistance training in humans. Fortetropin is made from fertilized chicken egg yolks using a process that retains the biological integrity and bioactivity of the product.
More

Webull offers kinds of MYOS RENS Technology Inc stock information, including NASDAQ:MYOS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYOS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MYOS stock methods without spending real money on the virtual paper trading platform.